Abiopharma

News list

Dely Mark C 🟡 adjusted position in 9.4K shares of Vera Bradley, Inc. (VRA) at $3.02 Transaction Date: Mar 31, 2026 | Filing ID: 000002

Full text

News bot April 2, 2026, 12:22 a.m.
🔍 Dely Mark C (Executive)

Company: Vera Bradley, Inc. (VRA)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 22,112
- Total shares sold: 12,706
Detailed Transactions and Holdings:
- Sold 3,483 shares of Common Stock at $3.02 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 353,010.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 22,112 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 375,122.00 | transaction_form_type: 4 | Footnotes: F2
- Sold 9,223 shares of Common Stock at $3.02 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 365,899.00 | transaction_form_type: 4
Footnotes:
- F1: Represents shares withheld to fulfill tax withholding obligations with respect to the vesting of a previously granted restricted stock unit award.
- F2: Represents earned performance share award settled in shares of common stock.